Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-541,100
Closed -$18.8M 6165
2020
Q4
$18.8M Sell
541,100
-141,000
-21% -$3.97M 0.01% 1079
2020
Q3
$11.8M Sell
682,100
-53,800
-7% -$937K 0.01% 1238
2020
Q2
$12.1M Sell
735,900
-149,000
-17% -$2.27M 0.01% 1172
2020
Q1
$8.03M Buy
884,900
+612,000
+224% +$12.3M 0.01% 1312
2019
Q4
$5.8M Sell
272,900
-308,300
-53% -$6.84M ﹤0.01% 1914
2019
Q3
$13.3M Buy
581,200
+285,400
+96% +$6.51M 0.01% 1189
2019
Q2
$7.18M Sell
295,800
-93,600
-24% -$1.93M 0.01% 1660
2019
Q1
$5.05M Buy
389,400
+188,500
+94% +$3.3M ﹤0.01% 1772
2018
Q4
$3.03M Buy
200,900
+199,300
+12,456% +$5.16M ﹤0.01% 2290
2018
Q3
$63K Buy
+1,600
New +$72.1K ﹤0.01% 6321

Other funds holding ADNT

Citigroup's ADNT Position: Q2 2026 in Review

Citigroup reduced its Adient (ADNT) stake by 3.2% in Q2 2026, selling an estimated $71.8K and leaving 100,697 shares worth $1.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2992.

Citigroup first reported a position in ADNT in Q4 2016 and has held it in 39 quarters since. The position peaked at $29M in Q4 2018. 314 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Citigroup held 100,697 shares of Adient worth $1.85M as of Q2 2026.
  • Citigroup sold 3,359 Adient shares in Q2 2026, an estimated $71.8K.
  • Adient made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2992 holding.
  • Citigroup first reported a position in Adient in Q4 2016 and has held it in 39 quarters since.
  • Citigroup's Adient position peaked at $29M in Q4 2018.
  • 314 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.